Drug Discovery World

OCTOBER 12, 2023

His work remains a key component of every FDA-approved AAV therapeutic and will remain central to future advances. His work remains a key component of every FDA-approved AAV therapeutic and will remain central to future advances. He co-founded AskBio in 2001 and in October 2020, Bayer acquired AskBio for $4 billion.

Therapies 130

Therapies FDA Approval Clinical Trials Virus 130

Drug Discovery World

OCTOBER 12, 2023

His work remains a key component of every FDA-approved AAV therapeutic and will remain central to future advances. His work remains a key component of every FDA-approved AAV therapeutic and will remain central to future advances. He co-founded AskBio in 2001 and in October 2020, Bayer acquired AskBio for $4 billion.

Therapies 130

Therapies FDA Approval Clinical Trials Virus 130

Drug & Device Law

SEPTEMBER 1, 2023

The defendant in Gilead has developed multiple drugs used to treat or prevent infection with the AIDS virus, including several containing tenofovir disoproxil fumarate (“TDF”) as an active ingredient. See, e.g., here and here. That is the group of drugs that the plaintiffs allegedly used and that allegedly caused harmful side effects.

Production 64

Production Marketing Pharma Companies FDA Approval 64

Drug & Device Law

JANUARY 12, 2024

The defendant in Gilead has developed multiple drugs used to treat or prevent infection with the AIDS virus, including several containing tenofovir disoproxil fumarate (“TDF”). The court also assumed that physicians naturally would prescribe the “newer” TAF once the FDA approved it. at *48-*50. at *31, *32. Gilead , at *67-*71.

FDA Approval 105

FDA Approval Drugs Production FDA 105